PMID: 11922950Mar 30, 2002Paper

Progress in understanding the structure-activity relationships of P-glycoprotein

Advanced Drug Delivery Reviews
Terry R Stouch, Olafur Gudmundsson

Abstract

Efflux out of cells by P-glycoprotein (P-gp) represents a serious liability for pharmaceuticals, particularly for anti-cancer drugs. Consequently, identification of compounds as potential substrates is important for understanding their bioavailability. Also, the development of agents which reverse this multi-drug resistance phenotype has received considerable attention. Assays for determining these activities are reviewed. Recent literature and studies into the structure-activity relationships (SAR) of the resulting data are discussed. Multiple binding sites and other complicating factors have prevented the development of a truly general, conclusive SAR either for substrate or inhibitory activities. Consequently, many models have tended to address only very general properties, such as lipophilicity and size. However, progress has been made in the last few years toward more specific SAR suggesting well-defined structural features responsible for both activities. The future of understanding the details of P-gp SAR lies in more specific assays that target specific binding sites and mechanisms of action.

References

Jan 9, 1992·Biochemical Pharmacology·W T Beck, X D Qian
Jun 26, 1992·Journal of Medicinal Chemistry·A DhainautJ F Prost
Aug 19, 1992·International Journal of Cancer. Journal International Du Cancer·D C Wolf, S B Horwitz
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S V AmbudkarI Pastan
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·A Ramu, N Ramu
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H L PearceW T Beck
Feb 1, 1995·Journal of Bioenergetics and Biomembranes·G A Scarborough
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·A Ramu, N Ramu
Feb 23, 1993·Biochimica Et Biophysica Acta·C A DoigeF J Sharom
Feb 15, 1993·Biochemical and Biophysical Research Communications·P S BurtonN F Ho
Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U A Germann
Sep 27, 1996·Journal of Medicinal Chemistry·A DhainautG Atassi
Jun 1, 1997·Molecular Pharmacology·S ScalaS E Bates
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·S DeyS V Ambudkar
Feb 7, 1998·European Journal of Biochemistry·A B Shapiro, V Ling
Jun 1, 1997·Seminars in Cancer Biology·K UedaM Morishima
Mar 10, 1998·European Journal of Biochemistry·A Seelig
Apr 9, 1998·Critical Reviews in Clinical Laboratory Sciences·W van de VrieA M Eggermont
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Jun 23, 1999·Journal of Medicinal Chemistry·D BergerD Powell
Jul 27, 1999·Current Opinion in Chemical Biology·D A Smith, H van de Waterbeemd
Apr 25, 2000·International Journal of Antimicrobial Agents·M KawaseN Motohashi
Apr 28, 2000·International Journal of Clinical Pharmacology and Therapeutics·S NeuhoffH Spahn-Langguth
Jun 6, 2000·Advanced Drug Delivery Reviews·A H Schinkel
Jun 6, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T Osterberg, U Norinder
Aug 23, 2000·Molecular Pharmacology·C MartinR Callaghan
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R Krishna, L D Mayer
Dec 13, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T Osterberg, U Norinder
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·H Suzuki, Y Sugiyama

❮ Previous
Next ❯

Citations

May 25, 2007·Applied Microbiology and Biotechnology·Alicia Ponte-Sucre
Apr 12, 2007·Cancer Chemotherapy and Pharmacology·Sang Joon ShinHyun Cheol Chung
Dec 14, 2006·Cell and Tissue Research·Sibylle EndterCarsten Ehrhardt
May 21, 2005·Pharmaceutical Research·Kamonthip WiwattanawongsaSanae Keawnopparat
Jun 17, 2008·Pharmaceutical Research·Liying ZhangAlexander Tropsha
Apr 15, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·James BlanchetteNicholas A Peppas
Mar 11, 2004·International Journal of Pharmaceutics·Noha N SalamaNatalie D Eddington
May 25, 2011·Journal of Chemical Information and Modeling·Zhi WangAixia Yan
Jun 6, 2006·Molecular Pharmaceutics·Anand Balakrishnan, James E Polli
Feb 5, 2004·SAR and QSAR in Environmental Research·J C DeardenS A Thomson
Dec 8, 2010·Journal of Aerosol Medicine and Pulmonary Drug Delivery·John S PattonCarsten Ehrhardt
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Cristina SeralFrançoise Van Bambeke
Apr 30, 2009·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Alma HamidovicJill Kolesar
Nov 7, 2002·Biological & Pharmaceutical Bulletin·Toshiyuki SakaedaKatsuhiko Okumura
Jun 3, 2005·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Naomi Mizuno, Takuro Niwa
Aug 19, 2007·Expert Opinion on Drug Metabolism & Toxicology·Aristides DokoumetzidisNikoletta Fotaki
Jul 2, 2003·Pharmacogenomics·Toshiyuki SakaedaKatsuhiko Okumura
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Wolfgang Löscher, Heidrun Potschka
Jan 25, 2006·Journal of Pharmaceutical Sciences·Miguel Angel CabreraMarival Bermejo
Sep 28, 2010·Advanced Drug Delivery Reviews·Mark GumbletonMathew W Smith
Apr 7, 2010·Bioorganic & Medicinal Chemistry·Juan XiongYoshihisa Takaishi
Aug 15, 2009·Biochemical Pharmacology·Kelly E DesinoKenneth L Audus
Mar 24, 2009·European Journal of Medicinal Chemistry·Sergio Mares-SámanoJeffrey Penny
Jul 14, 2007·Advanced Drug Delivery Reviews·Valentino J Stella, Kwame W Nti-Addae
May 1, 2007·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·P LimtrakulC Duangrat
Apr 19, 2005·Medicinal Research Reviews·Ahcène BoumendjelAttilio Di Pietro
Jul 9, 2004·International Journal of Cancer. Journal International Du Cancer·Chuanxi Cai, Jianwen Chen
Nov 2, 2005·The Journal of Pharmacy and Pharmacology·L Harivardhan Reddy
Oct 12, 2010·Chemical Biology & Drug Design·Abdolhossein ZarrinRamin Miri
Mar 15, 2005·Toxicology Letters·David BalayssacFrançois Coudore
May 26, 2004·International Journal of Pharmaceutics·Gilles CornaireGeorges Houin
Nov 14, 2006·Advanced Drug Delivery Reviews·Cheng ChangPeter W Swaan
Jul 14, 2005·Progress in Neurobiology·Wolfgang Löscher, Heidrun Potschka
Nov 18, 2010·Journal of Drug Targeting·Sheraz KhanAfzal R Mohammed
Mar 5, 2004·Journal of Pharmaceutical Sciences·Vijay K GombarCosette S Serabjit-Singh
Jan 27, 2004·Journal of Chemical Information and Computer Sciences·Marc Adenot, Roger Lahana
Jun 19, 2004·Journal of Drug Targeting·Remigijus DidziapetrisAlanas Petrauskas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)
J Lister-JamesR T Dean
© 2022 Meta ULC. All rights reserved